Evidence map›Paper›PMID 19342694›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.

Ashutosh Mangalam, David Luckey, Eati Basal, Megan Jackson, Michele Smart, Moses Rodriguez, Chella David

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The DQB1Frontiers in neurology · 2020
    Article
  15. Human CommensalFrontiers in immunology · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in immunology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ashutosh MangalamDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
David Luckey
Eati Basal
Megan Jackson
Michele Smart
Moses Rodriguez
Chella David
Mayo Clinic · US

Funding

T cell Function in Murine Model of Multiple SclerosisR01NS032129 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 1994 to 2010
$2.7M
IMMUNE PROMOTION OF REMYELINATIONR01NS024180 · NINDS · MAYO CLINIC ROCHESTER · PI RODRIGUEZ, MOSES · 1987 to 2008
$2.7M
Role of HLA Class II Genes in DemyelinationR01NS052173 · NINDS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S · 2006 to 2014
$2.5M
CSR NIH HHS RG3172NCI NIH HHS CA1011-03NINDS NIH HHS NS0521732NINDS NIH HHS NS24180NINDS NIH HHS NS32149NINDS NIH HHS R01 NS024180NINDS NIH HHS R01 NS032129NINDS NIH HHS R01 NS052173
6 · The paper itself

Abstract

Among all of the genetic factors associated with multiple sclerosis (MS) susceptibility, MHC class II molecules have the strongest association. Although a direct role of DR alleles in MS have been confirmed, it has been difficult to understand the role of DQ alleles in disease pathogenesis due to strong linkage disequilibrium with certain DR alleles. Population studies have indicated that DQ alleles may play a modulatory role in progression of MS. Using HLA class II transgenic (Tg) mice, we investigated gene complementation between DR and DQ genes in the disease process. Previously, using single Tg mice (expressing HLA-DR or DQ gene), we showed that PLP(91-110) peptide induced experimental autoimmune encephalomyelitis (EAE) only in DR3.Abeta degrees mice, suggesting that DR3 (DRB1*0301) is a disease susceptibility gene in the context of PLP. We also showed that DQ6 protects development of EAE in DQ6/DR3 double Tg mice by production of anti-inflammatory IFN-gamma. In this study, we investigated the ability of DQ8 to modulate disease in DR3/DQ8 double Tg mice. Introduction of DQ8 onto DR3 Tg mice led to higher disease incidence and increased disease severity on immunization with PLP(91-110), indicating that DQ8 had an exacerbating effect on the development of EAE. Increased susceptibility in DR3/DQ8 Tg mice was due to increased production of proinflammatory cytokine IL-17 by DQ8-restricted T cells. HLA-DR3/DQ8 mice with EAE also demonstrated increased inflammation and demyelination in CNS as compared with single DR3 Tg mice. Thus double Tg mouse provides a novel model to study epistatic interactions between HLA class II molecules in inflammatory and demyelinating disease.

Indexed as

AnimalsCell MovementEncephalomyelitis, Autoimmune, ExperimentalHistocompatibility Antigens Class IIHLA-DQ AntigensHLA-DR3 AntigenInterferon-gammaInterleukin-17MiceMice, TransgenicT-Lymphocytes, Helper-InducerHistocompatibility Antigens Class IIHLA-DQ8 antigenHLA-DQ AntigensHLA-DR3 AntigenInterferon-gammaInterleukin-17

Identifiers

PMID19342694
PMCPMC2665933
OpenAlexW1656161741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.